MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide): Gold-Standard Tetrazolium Salt for Cell Viability Assays

Executive Summary: MTT (APExBIO B7777) is a cationic tetrazolium salt enabling quantitative, colorimetric measurement of cell viability and metabolic activity in vitro (product page). Its reduction by NADH-dependent mitochondrial oxidoreductases yields insoluble formazan, directly proportional to viable cell number [1]. MTT is membrane-permeable, highly pure (≥98%), and optimally soluble in DMSO (≥41.4 mg/mL), supporting diverse assay formats [2]. Widely adopted in cancer and apoptosis research, MTT assays offer high sensitivity and reproducibility [3]. Correct use requires attention to storage (-20°C), solubility, and short-term solution stability (APExBIO).

Biological Rationale

MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) is extensively validated for measuring cell viability, proliferation, and metabolic activity. The assay’s principle is based on the reduction of MTT to formazan by viable cells, a process which is dependent on cellular metabolic competence, primarily via mitochondrial activity [1]. MTT’s ability to penetrate live cell membranes without auxiliary transporters distinguishes it from second-generation, anionic tetrazolium salts [4]. This property enables robust assessment of cell health in a range of applications, including oncology, neurobiology, and drug toxicity studies.

Mechanism of Action of MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide)

MTT is a yellow, water-soluble tetrazolium salt. Upon entry into viable cells, it is reduced mainly by NADH-dependent mitochondrial oxidoreductases and, to a lesser extent, by extra-mitochondrial enzymes (APExBIO). The reduction yields purple, insoluble formazan crystals, which accumulate intracellularly. The quantity of formazan formed is stoichiometrically proportional to the number of metabolically active cells [5]. After incubation (commonly 1–4 hours at 37°C, 5% CO₂), formazan is solubilized (typically in DMSO or ethanol) for absorbance measurement at 570 nm. This quantitative readout forms the basis for cell viability and proliferation studies.

Evidence & Benchmarks

• MTT reduction correlates linearly with viable cell number across a dynamic range of multiple cell types and densities (https://cytochrome-c-pigeon-88-104.com/index.php?g=Wap&m=Article&a=detail&id=15844).
• In multidrug resistance (MDR) studies, MTT assays reliably quantify cell survival after chemotherapeutic treatment, as shown in studies involving ABCB1-overexpressing cancer cell lines (https://www.ajtr.org/files/ajtr0023938.pdf, see Figure 1C and methods section).
• MTT is highly soluble in DMSO (≥41.4 mg/mL), moderately in ethanol (≥18.63 mg/mL), and slightly in water (≥2.5 mg/mL with ultrasonication), supporting broad experimental compatibility (https://www.apexbt.com/mtt.html).
• Formazan absorbance at 570 nm is reproducible with coefficients of variation <5% under standardized conditions (https://annexin-v-cy3.com/index.php?g=Wap&m=Article&a=detail&id=54).
• MTT-based cell viability measurement is accepted as a gold standard for metabolic activity assessment in cancer, apoptosis, and cytotoxicity research (https://cellron.com/index.php?g=Wap&m=Article&a=detail&id=50).

Applications, Limits & Misconceptions

MTT assays are used to:

• Quantify cell viability and proliferation in response to drugs, genetic modifications, or environmental conditions.
• Screen cytotoxicity in anticancer, antimicrobial, and neuroactive compound research [5].
• Monitor apoptosis and metabolic suppression, often paired with mechanistic markers [3].
• Benchmark cell line responses in multidrug resistance studies, particularly in ABCB1-overexpressing models (see Wallichinine study, https://www.ajtr.org/files/ajtr0023938.pdf).

Unlike some newer tetrazolium salts, MTT’s formazan product is insoluble, necessitating an additional solubilization step before absorbance reading [4]. MTT cannot distinguish between different cell death modalities (e.g., apoptosis vs. necrosis) without additional markers.

Common Pitfalls or Misconceptions

• MTT does not measure membrane integrity directly; it reflects metabolic activity.
• Formazan solubilization is mandatory; undissolved crystals yield unreliable absorbance data.
• Short-term MTT solutions are recommended; prolonged storage leads to degradation and reduced assay sensitivity.
• MTT is not suitable for non-adherent cell types unless appropriate centrifugation or immobilization steps are included.
• Assays do not differentiate between mitochondrial and non-mitochondrial reduction sources.

Workflow Integration & Parameters

The MTT assay is adaptable to 96-well, 24-well, or high-throughput formats. Typical workflow:

1. Plate cells at desired density in appropriate media and incubate (e.g., 24–48 h, 37°C, 5% CO₂).
2. Add MTT solution (final concentration: 0.2–0.5 mg/mL), incubate 1–4 h.
3. Remove supernatant and add solubilization reagent (DMSO or ethanol) to dissolve formazan.
4. Read absorbance at 570 nm (reference 630–690 nm optional for background correction).

For best results, use high-purity MTT (≥98%, such as APExBIO B7777) and prepare fresh solutions. Store dry powder at -20°C. For detailed troubleshooting and scenario-driven guidance, see this article, which details how this page extends standard protocols with advice for reproducibility in challenging setups.

In contrast to recent mechanistic reviews that focus on neuroinflammation, this article emphasizes benchmarked performance and multidrug resistance applications.

For a strategic, translational oncology perspective, see this resource; the present article provides updated quantitative solubility and storage parameters not covered in detail elsewhere.

Conclusion & Outlook

MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide, APExBIO B7777) remains a gold-standard for in vitro cell viability and proliferation assays due to its mechanistic specificity, quantitative reliability, and broad compatibility. Its adoption in metabolic activity, cancer, and apoptosis research is well-supported by extensive benchmarks and practical workflows. Ongoing improvements in assay integration and multiplexing are likely to further extend its utility in translational research and high-throughput screening.

For authoritative sourcing and product information, consult the MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) product page at APExBIO.